학술논문
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials
Document Type
Article
Author
Bellmunt, J.; de Wit, R.; Fradet, Y.; Climent, M.A.; Petrylak, D.P.; Lee, J.-L.; Fong, L.; Necchi, A.; Sternberg, C.N.; O’Donnell, P.H.; Powles, T.; Plimack, E.R.; Bajorin, D.F.; Balar, A.V.; Castellano, D.; Choueiri, T.K.; Culine, S.; Gerritsen, W.; Gurney, H.; Quinn, D.I.; Vuky, J.; Vogelzang, N.J.; Cristescu, R.; Loboda, A.; Lunceford, J.; Ma, J.; Saadatpour, A.; Rajasagi, M.; Godwin, J.L.; Moreno, B.H.; Grivas, P.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 15 May 2022, 28(10):2050-2060)
Subject
Language
English
ISSN
15573265
10780432
10780432